Insider filing · BBIO
Ronald J Daniels
Director
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Ronald J Daniels sold $3.9M of BridgeBio Pharma (BBIO)
Executed Nov 6 2025, disclosed Nov 7 2025, 1 day later.
Value, as filed
$3.9M
61,031 sh × $63.72
Executed
Nov 6 2025
the trade date, as filed
Disclosed
Nov 7 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RDRonald J Daniels (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $3.9M of BBIO (61,031 sh × $63.72, as filed), executed Nov 6 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→